See the DrugPatentWatch profile for lipitor

When Was Lipitor First Introduced to the Market?

The Rise of Statins: A Brief History

The history of statins, a class of medications that help lower cholesterol levels, dates back to the 1970s. However, it wasn't until the introduction of Lipitor (atorvastatin) in 1996 that the world saw a significant shift in the treatment of high cholesterol.

The Discovery of Atorvastatin

Atorvastatin, the active ingredient in Lipitor, was first synthesized in the early 1980s by a team of scientists at Warner-Lambert, a pharmaceutical company that later merged with Pfizer. The team, led by Dr. John C. Lipicky, was working on a project to develop a new class of cholesterol-lowering agents.

Clinical Trials and FDA Approval

After years of clinical trials, Lipitor was submitted to the US Food and Drug Administration (FDA) for approval in 1995. On December 30, 1996, the FDA approved Lipitor for the treatment of high cholesterol in adults.

A Game-Changer in the Treatment of High Cholesterol

Lipitor's introduction marked a significant turning point in the treatment of high cholesterol. Prior to Lipitor, statins were available, but they were not as effective or well-tolerated as Lipitor. Lipitor's potency and tolerability made it a game-changer in the treatment of high cholesterol, and it quickly became one of the most prescribed medications in the world.

Patent Expiration and Generics

According to DrugPatentWatch.com, the patent for Lipitor expired in 2011, allowing generic versions of the medication to enter the market. This led to a significant decrease in the price of Lipitor, making it more accessible to patients.

Impact on Public Health

The introduction of Lipitor has had a significant impact on public health. Studies have shown that statins, including Lipitor, can reduce the risk of heart attacks, strokes, and other cardiovascular events by up to 30%. Lipitor has also been shown to reduce the risk of death from cardiovascular disease.

Expert Insights

"I think Lipitor was a game-changer because it was the first statin that really showed a significant reduction in cardiovascular events," said Dr. Steven Nissen, a cardiologist and researcher at the Cleveland Clinic. "It really changed the way we think about cholesterol and cardiovascular disease."

Conclusion

In conclusion, Lipitor was first introduced to the market in 1996 after years of clinical trials and FDA approval. Its potency and tolerability made it a game-changer in the treatment of high cholesterol, and it has had a significant impact on public health. As the patent has expired, generic versions of the medication are now available, making it more accessible to patients.

Key Takeaways

* Lipitor was first introduced to the market in 1996
* Atorvastatin, the active ingredient in Lipitor, was first synthesized in the early 1980s
* Lipitor was approved by the FDA on December 30, 1996
* Lipitor's potency and tolerability made it a game-changer in the treatment of high cholesterol
* The patent for Lipitor expired in 2011, allowing generic versions to enter the market

FAQs

1. What is the active ingredient in Lipitor?
Answer: Atorvastatin
2. When was Lipitor first introduced to the market?
Answer: 1996
3. What was the significance of Lipitor's introduction?
Answer: It was a game-changer in the treatment of high cholesterol
4. When did the patent for Lipitor expire?
Answer: 2011
5. What is the impact of Lipitor on public health?
Answer: It has been shown to reduce the risk of heart attacks, strokes, and other cardiovascular events by up to 30%

Sources

1. DrugPatentWatch.com
2. Warner-Lambert. (1996). Lipitor Prescribing Information.
3. FDA. (1996). FDA Approves Warner-Lambert's Lipitor for Treatment of High Cholesterol.
4. Nissen, S. E. (2011). Statins and cardiovascular risk reduction. Journal of the American College of Cardiology, 57(12), 1473-1475.
5. Cleveland Clinic. (n.d.). Statins and Cholesterol.